Compugen Ltd. (CGEN) — Stock Score Summary

Compugen Ltd. (CGEN) has a MoatMap StockRank of 93/100 based on Quality (66/100), Value (52/100), and Momentum (62/100) factor scores. The current signal is STRONG BUY. N/A

Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in immunology and oncology, utilizing a proprietary computational discovery platform to identify novel drug targets. Its core strength lies in its predictive biology platform, which allows for the discovery of new immune checkpoints and therapeutic proteins, differentiating it from traditional drug discovery approaches. Compugen is a pioneer in predictive computational discovery, aiming to develop first-in-class immunotherapies.

Key Financial Metrics

Price$2.65
Market Cap$265M
P/E (TTM)6.97
P/E (Forward)-7.26
Price/Book2.63
Return on Equity45.7%
Return on Invested Capital23.4%
Debt/Equity3.08
Gross Margin88.1%
Operating Margin-414.4%
Revenue Growth-4.7%

Compugen Ltd. operates in the Biotechnology industry, part of the Healthcare sector (Israel).

Frequently Asked Questions

What is Compugen Ltd.’s (CGEN) StockRank?
MoatMap’s StockRank for Compugen Ltd. (CGEN) is 93/100, with a Strong Buy signal. It is a composite of Quality (66), Value (52), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Compugen Ltd. have an economic moat?
Compugen Ltd. (CGEN) has a Quality factor score of 66/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Compugen Ltd. a buy, hold, or sell?
MoatMap’s current signal for Compugen Ltd. (CGEN) is Strong Buy, based on a StockRank of 93/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Compugen Ltd. in?
Compugen Ltd. (CGEN) operates in the Healthcare sector, specifically the Biotechnology industry (Israel).
Browse all ranked stocksCGEN deep dive reportAI ChampionsHow we score stocksSense-check another stock